中医药学报
中醫藥學報
중의약학보
ACTA CHINESE MEDICINE AND PHARMACOLOGY
2014年
3期
93-96
,共4页
吕宇%黄立中%毛丹%戴新军%杨菊%张思泉
呂宇%黃立中%毛丹%戴新軍%楊菊%張思泉
려우%황립중%모단%대신군%양국%장사천
益气活血化瘀%乳腺癌%化疗%临床疗效
益氣活血化瘀%乳腺癌%化療%臨床療效
익기활혈화어%유선암%화료%림상료효
Yiqi Huoxue Huayu method%Breast cancer%Chemotherapy%Clinical efficacy
目的:观察益气活血化瘀方配合化疗治疗晚期乳腺癌的临床疗效。方法:将54例复发转移性晚期乳腺癌患者随机分为两组,治疗组27例,采用自拟益气活血化瘀方配合FAC方案治疗,对照组27例,单纯应用FAC方案治疗。两组均于4周期化疗后评定疗效,分别观察近期疗效、生活质量、不良反应发生情况及免疫学指标、肿瘤标志物等变化。结果:入组54例病例,无脱落病例,总有效率治疗组70.37%,对照组40.74%,两组比较差异有统计学意义( P<0.05);生存质量改善情况,治疗组和对照组KPS评分提高稳定率分别为92.59%,66.67%,两组比较,差异显著(P<0.05);治疗组治疗过程中白细胞、血小板、血红蛋白下降和恶心呕吐、神经毒性及心电图改变的发生均明显低于对照组,两组比较差异具有统计学意义(P<0.05);免疫学指标变化,治疗组CD3+,CD4+及NK细胞活性明显升高,CD8+明显降低,对照组患者治疗后CD3+、CD4+细胞活性明显降低,差异具有统计学意义( P<0.05);两组治疗后CEA、CA153与本组治疗前及两组治疗后比较差异均有统计学意义( P<0.05)。结论:益气活血化瘀法联合化疗治疗晚期乳腺癌能控制病情发展,提高患者生活质量,减轻化疗的不良反应,提高细胞免疫功能,具有较好的疗效。
目的:觀察益氣活血化瘀方配閤化療治療晚期乳腺癌的臨床療效。方法:將54例複髮轉移性晚期乳腺癌患者隨機分為兩組,治療組27例,採用自擬益氣活血化瘀方配閤FAC方案治療,對照組27例,單純應用FAC方案治療。兩組均于4週期化療後評定療效,分彆觀察近期療效、生活質量、不良反應髮生情況及免疫學指標、腫瘤標誌物等變化。結果:入組54例病例,無脫落病例,總有效率治療組70.37%,對照組40.74%,兩組比較差異有統計學意義( P<0.05);生存質量改善情況,治療組和對照組KPS評分提高穩定率分彆為92.59%,66.67%,兩組比較,差異顯著(P<0.05);治療組治療過程中白細胞、血小闆、血紅蛋白下降和噁心嘔吐、神經毒性及心電圖改變的髮生均明顯低于對照組,兩組比較差異具有統計學意義(P<0.05);免疫學指標變化,治療組CD3+,CD4+及NK細胞活性明顯升高,CD8+明顯降低,對照組患者治療後CD3+、CD4+細胞活性明顯降低,差異具有統計學意義( P<0.05);兩組治療後CEA、CA153與本組治療前及兩組治療後比較差異均有統計學意義( P<0.05)。結論:益氣活血化瘀法聯閤化療治療晚期乳腺癌能控製病情髮展,提高患者生活質量,減輕化療的不良反應,提高細胞免疫功能,具有較好的療效。
목적:관찰익기활혈화어방배합화료치료만기유선암적림상료효。방법:장54례복발전이성만기유선암환자수궤분위량조,치료조27례,채용자의익기활혈화어방배합FAC방안치료,대조조27례,단순응용FAC방안치료。량조균우4주기화료후평정료효,분별관찰근기료효、생활질량、불량반응발생정황급면역학지표、종류표지물등변화。결과:입조54례병례,무탈락병례,총유효솔치료조70.37%,대조조40.74%,량조비교차이유통계학의의( P<0.05);생존질량개선정황,치료조화대조조KPS평분제고은정솔분별위92.59%,66.67%,량조비교,차이현저(P<0.05);치료조치료과정중백세포、혈소판、혈홍단백하강화악심구토、신경독성급심전도개변적발생균명현저우대조조,량조비교차이구유통계학의의(P<0.05);면역학지표변화,치료조CD3+,CD4+급NK세포활성명현승고,CD8+명현강저,대조조환자치료후CD3+、CD4+세포활성명현강저,차이구유통계학의의( P<0.05);량조치료후CEA、CA153여본조치료전급량조치료후비교차이균유통계학의의( P<0.05)。결론:익기활혈화어법연합화료치료만기유선암능공제병정발전,제고환자생활질량,감경화료적불량반응,제고세포면역공능,구유교호적료효。
Objective:To observe the clinical effect for Yiqi Huoxue Huayu method combined with chemotherapy on ad -vanced breast cancer .Methods:Select 54 patients with advanced breast cancer and they were randomly divided into two groups .27 patients in treatment group were administered with “FAC chemotherapy combined with Chinese herbs”;27 patients in control group were with “FAC chemotherapy”.Observe the changes with tumor size , KPS, toxic side effects ,immunology indexes and the values of CEA and CA 153 between groups after four cycles of chemotherapy .Results:The effective rate in the treatment group was 70.37%;the control group was 40.74%, and there was a significant difference ( P<0 .05 ) .The KPS score increase stable rate of treatment group and the control group were respectively 92 .59%and 66.67%, and there was a significant difference (P<0.05).In treatment group, the incidences of the classes of leuko-cyte, platelet and hemoglobin degression , nausea and vomiting , neurotoxicity and ECG changes were significantly lower than those of the control group (P<0.05).After treatment,the immune indexes of CD3 +,CD4 +and NK cells were sig-nificantly increased and the immune indexes of CD8+was decreased in treatment group, and in control group,the im-mune indexes of CD3 +, CD4 + were significantly decreased .By comparison, those differences were significant ( P <0.05 ) .There were also differences between two groups in CEA and CA 15-3 after treatment ( P<0 .05 ) .Conclusion:Traditional Chinese medicine method with Yiqi Huoxue Huayu method can control the progress of advanced breast canc -er, raise life quality, alleviate the side effect of chemotherapy and improve immune function .